ESC 365 - Comparing biomarker profiles in patients with stable atherosclerosis treated with anacetrapib versus placebo: a nested proteomic study from HPS3/TIMI 55-REVEAL

ESC Premium Access

Comparing biomarker profiles in patients with stable atherosclerosis treated with anacetrapib versus placebo: a nested proteomic study from HPS3/TIMI 55-REVEAL

Session: Poster Session 5 - Acute coronary syndrome treatment

Topic: Pharmacotherapy

Speaker: Doctor D. Berg (Boston, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor David Berg

Brigham and Women's Hospital, Boston (United States of America)

2 presentations

0 follower

12 more presentations in this session

Strict versus no fasting prior to cardiac catheterization: a prospective evaluation of safety and clinical outcomes

Speaker: Doctor A. Mishra (Sayre, US)

Intraventricular conduction disturbance and ventricular paced rhythms in patients with acute coronary syndromes

Speaker: Doctor P. Azevedo (Faro, PT)

Reduced exercise capacity and clinical outcomes following acute myocardial infarction

Speaker: Doctor H. Tashiro (Nagoya, JP)

Ultrasound targeted delivery of exosomes derived from bone mesenchymal stem cells stimulate angiogenesis and reduce adverse remodeling after myocardial infarction

Speaker: Doctor Q. Deng (Wuhan, CN)

Exercise training after acute coronary syndromes in the octogenarians has beneficial effect on the course of the disease and the exercise tolerance - single-center, prospective 12-months evaluation.

Speaker: Professor R. Dabrowski (Warsaw, PL)

Access the full session

Poster Session 5 - Acute coronary syndrome treatment

Speakers: Doctor D. Berg, Doctor A. Mishra, Doctor P. Azevedo, Doctor H. Tashiro, Doctor Q. Deng...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources